DB19335InvestigationalProtein Based Therapies
Peginterferon Alfacon-2 is under investigation in clinical trial NCT06544551 (Efficacy and Safety Study of Peginterferon Alfacon-2 to Treat Chronic Hepatitis B Virus Infection).
- Also known as
- Interferon .alpha.1 (synthetic), n-terminal 20-kilodalton pegylated · Peg-interferon Alfacon-2
Resolves to
Compound
Clinical / RWD
What you can answer from here — as of October 29, 2025
Which companies are running trials of Peginterferon Alfacon-2, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account